Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review

Immune-mediated inflammatory diseases (IMIDs) are chronic conditions that create a significant disease burden on millions of patients while adding a major financial burden to societies and healthcare systems. The introduction of biologic medicines has contributed majorly to improving the clinical ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezk, Mourad F., Pieper, Burkhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444394/
https://www.ncbi.nlm.nih.gov/pubmed/32740789
http://dx.doi.org/10.1007/s12325-020-01437-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444394/
https://www.ncbi.nlm.nih.gov/pubmed/32740789
http://dx.doi.org/10.1007/s12325-020-01437-4

Ejemplares similares